Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist
Upadhyaya, P., Lahdenranta, J., Hurov, K. et al. Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist. J Immunother Cancer. (2021). http://dx.doi.org/10.1136/jitc-2020-001762
Read more
B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes
You, G., Lee, Y., Kang, Y.-W. et al. B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes. Sci Adv. (2021). DOI: 10.1126/sciadv.aax3160
Read more
